Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-23T08:25:45.142Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacotherapy in paediatric heart failure: a Delphi process

Published online by Cambridge University Press:  24 June 2019

Cristina C. Díez ,
Feras Khalil ,
Nina Makowski ,
Holger Schwender ,
Ida Jovanovic ,
Michiel Dalinghaus ,
Jennifer Walsh ,
Marijke van der Meulen ,
Milica Bajcetic  and
Saskia N. de Wildt
...Show all authors
Cristina C. Díez
Affiliation:
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Germany
Feras Khalil
Affiliation:
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Germany
Nina Makowski
Affiliation:
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Germany
Holger Schwender
Affiliation:
Mathematical Institute, Heinrich-Heine-University Düsseldorf, Germany
Ida Jovanovic
Affiliation:
Department of Paediatric Cardiology, University Children’s Hospital, Belgrade, Serbia
Michiel Dalinghaus
Affiliation:
Department of Paediatric Cardiology, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
Jennifer Walsh
Affiliation:
Jenny Walsh Consulting Ltd, BioCity Nottingham, UK
Marijke van der Meulen
Affiliation:
Department of Paediatric Cardiology, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
Milica Bajcetic
Affiliation:
Department of Clinical Pharmacology, University Children’s Hospital, Belgrade, Serbia Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Serbia
Saskia N. de Wildt
Affiliation:
Department of Pharmacology and Toxicology, Radboud University, Nijmegen, The Netherlands Intensive Care and Department of Paediatric Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
Stephanie Läer*
Affiliation:
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Germany
*
Author for correspondence: Prof. Dr Stephanie Läer, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, Gebäude 26.22, Ebene 02 Raum 24, 40225 Düsseldorf, Germany. Tel: +49 211 8110740; Fax: +49 211 8110741; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Little evidence exists to support pharmacotherapeutic strategies for heart failure management in paediatrics. A recent Europe-wide survey suggests that this translates into substantial variability in clinical practice.

Objective:

To conduct a formal discussion among an expert group of paediatric cardiology physicians on controversial aspects regarding the pharmacotherapy of children heart failure, facilitate consensus, and highlight areas of agreement and disagreement.

Methods:

A two-round modified Delphi process was conducted between July and August 2015. Topics addressed were predominantly selected from the results of a previous Europe-wide survey. Fourteen statements were presented for discussion grouped under three categories; Angiotensin-converting-enzyme-inhibitors: Considerations for optimal dosage; Angiotensin-converting-enzyme-inhibitors for the management of CHDs; Neurohumoral antagonists for the management of dilated cardiomyopathy-related heart failure.

Results:

A total of 13 paediatricians dedicated to cardiology from across Europe and the United States of America completed the study; of them, 92% had a working experience in the field of more than 10 years and were working in a specific paediatric cardiology unit. Agreement on the acceptance/rejection of 11 statements was achieved. Results show agreement on the importance of a set of topics relevant to the standardisation of the therapy as well as consensus upon specific therapeutic attitudes.

Conclusions:

We have found areas of common thinking and motivation, which can provide a means of triggering scientific collaboration. Our results might also contribute to disseminate available paediatric evidence and promote reducing unjustified variability in everyday practice. Until solid evidence is available, other research methods can contribute to advancing the goal of safe and effective paediatric heart failure pharmacotherapy.

Keywords

Delphiheart failurepaediatricspharmacotherapyangiotensin-converting-enzyme-inhibitors
Type
Original Article
Information
Cardiology in the Young , Volume 29 , Issue 7 , July 2019 , pp. 869 - 876
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Castro Díez C, Khalil F, Schwender H, Dalinghaus M, Jovanovic I, Makowski N, Male C, Bajcetic M, van der Meulen M, de Wildt SN., Ablonczy L, Szatmári A (†), Klingmann I, Walsh J, Läer S. Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European survey. Published 31st January 2019 BMJ Paediatrics Open. Available from http://bmjpaedsopen.bmj.com/cgi/content/abstract/10.1136/bmjpo-2018-000365.

References

Bajcetic, M, Jelisavcic, M, Mitrovic, J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol 2005; 61: 775–779. doi: 10.1007/s00228-005-0981-yCrossRefGoogle ScholarPubMed
Kantor, PF, Lougheed, J, Dancea, A, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can J Cardiol 2013; 29: 1535–1552. doi: 10.1016/j.cjca.2013.08.008CrossRefGoogle ScholarPubMed
Kirk, R, Dipchand, AI, Rosenthal, DN, et al. The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary. [corrected]. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 2014; 33: 888–909. doi: 10.1016/j.healun.2014.06.002CrossRefGoogle Scholar
EMEA. Evidence of harm from off-label or unlicensed medicines in children. 2004. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/10/WC500004021.pdfGoogle Scholar
Kennedy, PJ, Leathley, CM, Hughes, CF. Clinical practice variation. Med J Aust 2010; 193: S97–S99.10.5694/j.1326-5377.2010.tb04021.xCrossRefGoogle ScholarPubMed
Li, JS, Colan, SD, Sleeper, LA, et al. Lessons learned from a pediatric clinical trial: the pediatric heart network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J 2011; 161: 233–240. doi: 10.1016/j.ahj.2010.10.030CrossRefGoogle ScholarPubMed
Rossano, JW, Shaddy, RE. Update on pharmacological heart failure therapies in children: do adult medications work in children and if not, why not? Circulation 2014; 129: 607–612. doi: 10.1161/CIRCULATIONAHA.113.003615CrossRefGoogle Scholar
Fick, DM, Cooper, JW, Wade, WE, et al. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–2724. doi: 10.1001/archinte.163.22.2716CrossRefGoogle ScholarPubMed
Gurvitz, M, Marelli, A, Mangione-Smith, R, et al. Building quality indicators to improve care for adults with congenital heart disease. J Am Coll Cardiol 2013; 62. doi: 10.1016/j.jacc.2013.07.099CrossRefGoogle ScholarPubMed
Jones, J, Hunter, D. Consensus methods for medical and health services research. BMJ 1995; 311: 376–380.CrossRefGoogle ScholarPubMed
Hasson, F, Keeney, S, McKenna, H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000; 32: 1008–1015.Google ScholarPubMed
Holt, S, Schmiedl, S, Thürmann, PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl Int 2010; 107: 543–551. doi: 10.3238/arztebl.2010.0543Google ScholarPubMed
Keeney, S, Hasson, F, McKenna, H. The Delphi technique in nursing and health research. 1st ed. Chichester, United Kingdom: Wiley-Blackwell 2011.Google Scholar
Dalkey, N. An experimental study of group opinion: the Delphi method. Futures 1969; 1: 408–426. doi: 10.1016/S0016-3287(69)80025-XCrossRefGoogle Scholar
Diamond, IR, Grant, RC, Feldman, BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 2014; 67: 401–409. doi: 10.1016/j.jclinepi.2013.12.002CrossRefGoogle ScholarPubMed
Dalkey, , Helmer-Hirschberg, O. An Experimental Application of the Delphi Method to the Use of Experts. Published Online First: 1962. Retrieved April 19, 2018, from https://www.rand.org/pubs/research_memoranda/RM727z1.htmlGoogle Scholar
Häder, M. Delphi-befragungen: Ein Arbeitsbuch. 3rd ed. Wiesbaden: Springer 2014.Google Scholar
Holey, EA, Feeley, JL, Dixon, J, et al. An exploration of the use of simple statistics to measure consensus and stability in Delphi studies. BMC Med Res Methodol 2007; 7: 52. doi: 10.1186/1471-2288-7-52CrossRefGoogle ScholarPubMed
Hsu, , Sandford, B. The Delphi technique: making sense of consensus. Pract Assess Res Eval 2007; 12: 1–8.Google Scholar
Medrano López, C, García-Guereta, L, Fernández Pineda, L, et al. [Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.]. An Pediatr Barc Spain 2003 2010; 72: 432.e1–432.e13. doi: 10.1016/j.anpedi.2010.03.001Google Scholar
Okoli, C, Pawlowski, S. The Delphi method as a research tool: an example, design considerations and applications. Inf Manage 2004; 42: 15–29. doi: 10.1016/j.im.2003.11.002CrossRefGoogle Scholar
Hamzeh, NY, Wamboldt, FS, Weinberger, HD. Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012; 141: 154–162. doi: 10.1378/chest.11-0263CrossRefGoogle ScholarPubMed
Hejblum, G, Ioos, V, Vibert, J-F, et al. A web-based Delphi study on the indications of chest radiographs for patients in ICUs. Chest 2008; 133: 1107–1112. doi: 10.1378/chest.06-3014CrossRefGoogle ScholarPubMed
Meijer, R, Ihnenfeldt, D, Vermeulen, M, et al. The use of a modified Delphi procedure for the determination of 26 prognostic factors in the sub-acute stage of stroke. Int J Rehabil Res Int Z Rehabil Rev Int Rech Readaptation 2003; 26: 265–270. doi: 10.1097/01.mrr.0000102660.02099.8fGoogle ScholarPubMed
Delbecq, A, Ven, A, Gustafson, D. Group techniques for program planning: A guide to nominal groups and Delphi processes. Gustafson Glenview, III.: Scott, Foresman, 1975.Google Scholar
Skulmoski, GJ, Hartman, F, Krahn, J. The Delphi method for graduate research. JITE 2007; 6: 1–21. doi: 10.28945/199Google Scholar
United Nations Secretariat, Statistics Division. Standard Country or area codes for statistical use (M49). Stand. Ctry. Area Codes Stat. Use M49. https://unstats.un.org/unsd/methodology/m49 (accessed 20 Apr 2018).Google Scholar
Andres, L. Designing & Doing Survey Research. 1st ed. London: SAGE 2012.CrossRefGoogle Scholar
Burns, KEA, Duffett, M, Kho, ME, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ Can Med Assoc J J Assoc Medicale Can 2008; 179: 245–252. doi: 10.1503/cmaj.080372CrossRefGoogle ScholarPubMed
Lozano, LM, García-Cueto, E, Muñiz, J. Effect of the number of response categories on the reliability and validity of rating scales. Methodology 2008; 4: 73–79. doi: 10.1027/1614-2241.4.2.73CrossRefGoogle Scholar
Schmidt, RC. Managing Delphi surveys using nonparametric statistical techniques. Decis Sci 2007; 28: 763–774. doi: 10.1111/j.1540-5915.1997.tb01330.xCrossRefGoogle Scholar
van der Meulen, M, Dalinghaus, M, Burch, M, et al. Question 1: How safe are ACE inhibitors for heart failure in children? Arch Dis Child 2018; 103: 106–109. doi: 10.1136/archdischild-2017-312774CrossRefGoogle ScholarPubMed
Taketomo, C, Hodding, J, Kraus, D. Pediatric & Neonatal Dosage Handbook. 23rd ed. Hudson, Ohio: Lexi-Comp, Inc 2016.Google Scholar
Ross, RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol 2012; 33: 1295–1300. doi: 10.1007/s00246-012-0306-8CrossRefGoogle Scholar
Ross, RD. Grading the graders of congestive heart failure in children. J Pediatr 2001; 138: 618–620. doi: 10.1067/mpd.2001.115707CrossRefGoogle ScholarPubMed
Connolly, D, Rutkowski, M, Auslender, M, et al. The New York University pediatric heart failure index: a new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644–648. doi: 10.1067/mpd.2001.114020CrossRefGoogle ScholarPubMed
Hsu, , Pearson, GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail 2009; 2: 63–70. doi: 10.1161/CIRCHEARTFAILURE.108.820217CrossRefGoogle ScholarPubMed
Mulla, H, Tofeig, M, Bu’Lock, F, et al. Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom. Arch Dis Child 2007; 92: 409–411. doi: 10.1136/adc.2006.109389CrossRefGoogle ScholarPubMed
Pabari, RM, McDermott, C, Barlow, J, et al. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation. Clin Ther 2012; 34: 2221–2229. doi: 10.1016/j.clinthera.2012.10.005CrossRefGoogle ScholarPubMed
Gibbons, RJ, Gardner, TJ, Anderson, JL, et al. The American heart association’s principles for comparative effectiveness research: a policy statement from the American heart association. Circulation 2009; 119: 2955–2962. doi: 10.1161/CIRCULATIONAHA.109.192518CrossRefGoogle ScholarPubMed
Francke, AL, Smit, MC, de Veer, AJE, et al. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008; 8: 38. doi: 10.1186/1472-6947-8-38CrossRefGoogle ScholarPubMed
Zak, V, Hsu, DT, Pemberton, VL, et al. Translating clinical trials into clinical practice: a survey assessing the potential impact of the pediatric heart network infant single ventricle trial. Cardiol Young 2017; 27: 1265–1270. doi: 10.1017/S104795111600295XCrossRefGoogle ScholarPubMed
Hsu, , Zak, V, Mahony, L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 2010; 122: 333–340. doi: 10.1161/CIRCULATIONAHA.109.927988CrossRefGoogle ScholarPubMed
Alehan, D, Ozkutlu, S. Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms. Am Heart J 1998; 135: 598–603.CrossRefGoogle ScholarPubMed
Calabrò, R, Pisacane, C, Pacileo, G, et al. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am Heart J 1999; 138: 955–961.CrossRefGoogle ScholarPubMed
Mori, Y, Nakazawa, M, Tomimatsu, H, et al. Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. J Am Coll Cardiol 2000; 36: 270–275.10.1016/S0735-1097(00)00673-2CrossRefGoogle ScholarPubMed
Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200. doi: 10.1093/eurheartj/ehw128CrossRefGoogle Scholar
Yancy, CW, Jessup, M, Bozkurt, B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart association task force on practice guidelines. Circulation 2013; 128: 1810–1852. doi: 10.1161/CIR.0b013e31829e8807CrossRefGoogle Scholar
Alabed, S, Sabouni, A, Al Dakhoul, S, et al. Beta-blockers for congestive heart failure in children. Cochrane database syst rev 2016; CD007037. doi: 10.1002/14651858.CD007037.pub3CrossRefGoogle Scholar
López-Sendón, J, Swedberg, K, McMurray, J, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25: 1454–1470. doi: 10.1016/j.ehj.2004.06.003Google ScholarPubMed
Towbin, JA, Lowe, AM, Colan, SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867–1876. doi: 10.1001/jama.296.15.1867CrossRefGoogle ScholarPubMed
Akins, RB, Tolson, H, Cole, BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 2005; 5: 37. doi: 10.1186/1471-2288-5-37CrossRefGoogle Scholar
Duffield, C. The Delphi technique: a comparison of results obtained using two expert panels. Int J Nurs Stud 1993; 30: 227–237.CrossRefGoogle ScholarPubMed
Supplementary material: PDF

Díez et al. supplementary material

Díez et al. supplementary material 1

Download Díez et al. supplementary material(PDF)
PDF 159.4 KB
Supplementary material: PDF

Díez et al. supplementary material

Díez et al. supplementary material 2

Download Díez et al. supplementary material(PDF)
PDF 106.1 KB
Supplementary material: PDF

Díez et al. supplementary material

Díez et al. supplementary material 3

Download Díez et al. supplementary material(PDF)
PDF 1.7 MB